These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 24704024
1. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. Xie K, Liu J, Chen J, Dong J, Ma H, Liu Y, Hu Z. Gene; 2014 Jun 10; 543(1):101-7. PubMed ID: 24704024 [Abstract] [Full Text] [Related]
2. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia. Ng HY, Wan TS, So CC, Chim CS. J Clin Pathol; 2014 Jul 10; 67(7):626-31. PubMed ID: 24811488 [Abstract] [Full Text] [Related]
3. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. Carcinogenesis; 2010 May 10; 31(5):766-76. PubMed ID: 19843643 [Abstract] [Full Text] [Related]
4. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Chen X, Hu H, Guan X, Xiong G, Wang Y, Wang K, Li J, Xu X, Yang K, Bai Y. Int J Cancer; 2012 Apr 01; 130(7):1607-13. PubMed ID: 21547903 [Abstract] [Full Text] [Related]
5. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671 [Abstract] [Full Text] [Related]
6. Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma. Lu CY, Lin KY, Tien MT, Wu CT, Uen YH, Tseng TL. Genes Chromosomes Cancer; 2013 Jul 01; 52(7):636-43. PubMed ID: 23580407 [Abstract] [Full Text] [Related]
7. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. Long XR, He Y, Huang C, Li J. Int J Oncol; 2014 Jun 01; 44(6):1915-22. PubMed ID: 24714841 [Abstract] [Full Text] [Related]
8. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Anwar SL, Albat C, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U. Int J Cancer; 2013 Aug 01; 133(3):660-70. PubMed ID: 23364900 [Abstract] [Full Text] [Related]
9. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Tanaka N, Toyooka S, Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K, Miyoshi S. Lung Cancer; 2012 Apr 01; 76(1):32-8. PubMed ID: 22047961 [Abstract] [Full Text] [Related]
10. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Huang J, Wang Y, Guo Y, Sun S. Hepatology; 2010 Jul 01; 52(1):60-70. PubMed ID: 20578129 [Abstract] [Full Text] [Related]
11. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Gallardo E, Navarro A, Viñolas N, Marrades RM, Diaz T, Gel B, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J, Monzo M. Carcinogenesis; 2009 Nov 01; 30(11):1903-9. PubMed ID: 19736307 [Abstract] [Full Text] [Related]
13. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer. Hiyoshi Y, Schetter AJ, Okayama H, Inamura K, Anami K, Nguyen GH, Horikawa I, Hawkes JE, Bowman ED, Leung SY, Harris CC. PLoS One; 2015 Nov 01; 10(4):e0124899. PubMed ID: 25894979 [Abstract] [Full Text] [Related]
14. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS. Genes Chromosomes Cancer; 2009 Dec 01; 48(12):1057-68. PubMed ID: 19760608 [Abstract] [Full Text] [Related]
15. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y. Carcinogenesis; 2010 Dec 01; 31(12):2066-73. PubMed ID: 20924086 [Abstract] [Full Text] [Related]
16. Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer. Chen H, Xu Z. Dis Markers; 2015 Dec 01; 2015():345080. PubMed ID: 26693202 [Abstract] [Full Text] [Related]
17. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Yang F, Li QJ, Gong ZB, Zhou L, You N, Wang S, Li XL, Li JJ, An JZ, Wang DS, He Y, Dou KF. Technol Cancer Res Treat; 2014 Feb 01; 13(1):77-86. PubMed ID: 23862748 [Abstract] [Full Text] [Related]
18. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K. Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447 [Abstract] [Full Text] [Related]
19. [Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR]. Liu ZR, Chen XW, Qiao XH, Wang R, Xiang Z. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr 02; 29(4):751-3. PubMed ID: 19403413 [Abstract] [Full Text] [Related]
20. hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U. World J Gastroenterol; 2017 Mar 07; 23(9):1568-1575. PubMed ID: 28321157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]